Lawsuits against NovoNordisk, the maker of Ozempic, claim the company did not
warn patients about the possible intestinal and gastric side effects, like gastroparesis, from using
Ozempic. The lawsuits also allege that the manufacturers were negligent in the testing and monitoring of
the drugs post-approval to ensure safety.
Anyone who took Ozempic and experienced stomach paralysis, blood clots, or other intestinal issues
may be
eligible to file a claim against the manufacturer for compensation.
Ozempic Class Action Lawsuit or Multi-District Litigation
In February 2024 all GLP-1 lawsuits were grouped together into one federal court for what is called a Multidistrict Litigation, or MDL. This grouping of cases is similar to a class action lawsuit, but follows a different legal process: every single person with a filed case will have a right to their own individual trial.
People affected by these severe side effects are seeking money for medical expenses, lost wages, pain and suffering, and other damages related to their health. They are also calling for more stringent regulatory actions and clearer, more comprehensive labeling of the drugs to prevent further cases.